Brain abscesses caused by Abiotrophia defectiva: Complication of immunosuppressive therapy in a patient with connective-tissue disease

Scandinavian Journal of Infectious Diseases

Volumn 36, Issue 6-7, 2004, Pages 497-499

  Zenone, Thierry ^a   Durand, Denis Vital ^b  

^a CENTRE HOSPITALIER DE VALENCE   (France)

^b CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CD4 ANTIGEN; CEFTAZIDIME; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DNA 16S; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; OFLOXACIN; PEFLOXACIN; PIPERACILLIN; PREDNISONE; PYRIMETHAMINE SULFADIAZINE; RIFAMPICIN; TICARCILLIN; VANCOMYCIN;

ABIOTROPHIA DEFECTIVA; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BLOOD CULTURE; BRAIN ABSCESS; BRAIN BIOPSY; BRAIN VASCULITIS; CASE REPORT; CONFUSION; CONNECTIVE TISSUE DISEASE; DIFFERENTIAL DIAGNOSIS; FEVER; HUMAN; HYPERGAMMAGLOBULINEMIA; IMMUNE DEFICIENCY; KERATOCONJUNCTIVITIS SICCA; LIVEDO RETICULARIS; LUPUS VULGARIS; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MALE; MICROBIOLOGICAL EXAMINATION; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PAROTID GLAND DISEASE; PERICARDIAL EFFUSION; PLEURA EFFUSION; POLYMERASE CHAIN REACTION; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SJOEGREN SYNDROME; TOXOPLASMA GONDII; TOXOPLASMOSIS; TREATMENT OUTCOME;

AGED; ANTI-BACTERIAL AGENTS; BRAIN ABSCESS; CYCLOPHOSPHAMIDE; GRAM-POSITIVE BACTERIAL INFECTIONS; GRAM-POSITIVE COCCI; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS; MALE; PREDNISONE; SJOGREN'S SYNDROME; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS;

EID: 4143112396     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540410016104     Document Type: Article

References (14)

1. Segal BH, Sneller MC. Infectious complications of immunosuppressive therapy in patients with rheumatic diseases. Rheum Dis Clin North Am 1997; 23: 219-37.
2. Bouvet A, Grimont F, Grimont PA. Streptococcus defectivus sp. Nov. and Streptococcus adjacens sp. Nov., nutritionally variant streptococci from human clinical specimens. Int J Syst Bacteriol 1989; 39: 290-4.
3. Kawamura Y, Hou XG, Sultana F, Liu S, Yamamoto H, Ezaki T. Transfer of Streptococcus adjacens and Streptococcus defectivus to Abiotrophia gen. Nov., as Abiotrophia adiacens comb. Nov. and Abiotrophia defectiva comb. Nov., respectively. Int J Syst Bacteriol 1995; 45: 798-803.
4. Collins MD, Lawson PA. The genus Abiotrophia (Kawamura et al.) is not monophyletic proposal of Granulicatella gen. Nov., Granulicatella adiacens comb. Nov., Granulicatella elegans comb. Nov. and Granulicatella balaenopterae comb. Nov Int J Syst Evol Microbiol 2000; 50: 365-9.
5. Roggenkamp A, Leitritz L, Baus K, Falsen E, Heesemann J. PCR for detection and identification of Abiotrophia spp. J Clin Microbiol 1998; 36: 2844-6.
6. Ruoff KL. Nutritionally variant streptococci. Clin Microbiol Rev 1991; 4: 184-90.
7. Schlegel L, Merlet C, Laroche JM, Frémaux A, Geslin P. Iatrogenic meningitis due to Abiotrophia defectiva after myelography. Clin Infect Dis 1999; 28: 155-6.
8. Ince A, Tiemer B, Gille J, Boos C, Russlies M. Total knee arthroplasty infection due to Abiotrophia defectiva. J Med Microbiol 2002; 51: 899-902.
9. Stein DS, Nelson KE. Endocarditis due to nutritionally deficient streptococci: therapeutic dilemma. Rev Infect Dis 1987; 9: 908-16.
10. Christensen JJ, Facklam RR. Granulicatella and Abiotrophia species from human clinical specimens. J Clin Microbiol 2001; 39: 3520-3.
11. Christensen JJ, Gruhn N, Facklam RR. Endocarditis caused by Abiotrophia species. Scand J Infect Dis 1999; 31: 210-2.
12. Wilson WR, and the Endocarditis Working Group of the International Society for Chemotherapy. Antibiotic treatment of infective endocarditis due to viridans streptococci, enterococci, and other streptococci. Clin Microbiol Infect 1998; 4: (Suppl 3) S17-26.
13. Cerceo E, Christie JD, Nachamkin I, Lautenbach E. Central nervous system infections due to Abiotrophia and Granulicatella species: an emerging challenge? Diagn Microbiol Infect Dis 2004; 48: 161-5.
14. Sieling PA, van de Rijn I. Evaluation of the immune response in protection against experimental Streptococcus defectivus endocarditis. J Lab Clin Med 1991; 117: 402-9.